Filing Details

Accession Number:
0001213900-21-043928
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-08-19 19:11:56
Reporting Period:
2021-08-17
Accepted Time:
2021-08-19 19:11:56
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1779020 Danimer Scientific Inc. DNMR Plastic Materials, Synth Resins & Nonvulcan Elastomers (2821) 841924518
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1836650 Eric Michael Smith C/O Danimer Scientific, Inc.
140 Industrial Boulevard
Bainbridge GA 39817
Chief Operating Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock ("Common Stock") Acquisiton 2021-08-17 10,000 $3.28 387,259 No 4 M Direct
Common Stock Disposition 2021-08-17 10,000 $14.73 377,259 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option Disposition 2021-08-17 10,000 $0.00 10,000 $3.28
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
668,909 2026-06-30 No 4 M Direct
Footnotes
  1. Includes 377,259 restricted shares of the Common Stock granted under a previously disclosed restricted stock award.
  2. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Smith on June 25, 2021. The Reporting Person exercised no discretion with respect to the sale. Proceeds from the sale were used to pay the exercise price of stock options, pursuant to a broker-assisted cashless exercise, and applicable withholding taxes.
  3. The August 17, 2021 sale of 10,000 shares of Common Stock was executed in multiple trades at prices ranging from $14.01 to $15.14. The price reported above reflects the volume-weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
  4. The options are fully vested and currently exercisable.
  5. Reflects the aggregate amount of options owned by Reporting Person having the exercise price, grant date and expiration date reported above, but which options were previously reported on two separate entries in a prior filing.